Clinical Trial

Effect of Continuous Glucose Monitoring System on Glycemic Control in Non-insulin-Treated Elderly People With Type 2 Diabetes

Study acronym: INTELLECT
Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to learn if continuous glucose monitoring system works to improve glucose control in non-insulin-treated older adults with type 2 diabetes. The main questions it aims to answer are: * Dose the use of continuous glucose monitoring system improve glucose control in older adults with type 2 diabetes treated with oral antidiabetic drugs only? * Dose the use of continuous glucose monitoring system affect psychological outcomes in older adults with type 2 diabetes treated with oral antidiabetic drugs only? Researchers will compare continuous glucose monitoring to standard blood glucose monitoring to see if continuous glucose monitoring works better in glucose management. Participants will: * Wear continuous glucose monitoring every 2 months or standard blood glucose monitoring for 6 months * Visit the clinic once every 2 months for follow-up * Keep a diary of their blood glucose when continuous glucose monitoring was not used
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-06-05; most recent amendment 2026-04-08.
Status change: Not Yet Recruiting → Recruiting 2025-09-02
Trial Details
NCT Number NCT07007676
Lead Sponsor Shanghai 6th People's Hospital
Collaborators: Shenzhen Center for Chronic Disease Control, Shenzhen Baoan District People's Hospital, Shenzhen Haile Community Health Service Station, Shenzhen Buxin Community Health Service Center, Shenzhen Dalang Community Health Service Center, Shenzhen Haihua Community Health Service Center, Shenzhen Pingzhou Community Health Service Center, Shenzhen Fifth Avenue Health Service Station, Shenzhen Haifu Health Service Station, Shenzhen Haile Huafu Health Service Station, Shenzhen Haiyu Health Service Station, Shenzhen Jiaan Health Service Station, Shenzhen Jiari Mingju Health Service Station, Shenzhen Jiangangshan Health Service Center, Shenzhen Xinan Lake Health Service Station, Shenzhen Xingdong Health Service Station, Shenzhen Zhongliang Chuangxin Health Service Station
Conditions Diabetes Mellitus Type 2
Enrollment 148 participants
Start Date 2025-07-14
Primary Completion 2027-02-28 (estimated)
Study Completion 2027-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-04-13